Kusumoto S - Search Results

1

[Preemptive therapy for HBV reactivation by serial HBV-DNA monitoring].

Kusumoto S, Tanaka Y, Mizokami M. Kusumoto S, et al. Nihon Shokakibyo Gakkai Zasshi. 2010 Sep;107(9):1441-9. Nihon Shokakibyo Gakkai Zasshi. 2010. PMID: 20827040 Japanese. No abstract available.

2

Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma.

Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Kusumoto S, et al. Int J Hematol. 2009 Jul;90(1):13-23. doi: 10.1007/s12185-009-0359-5. Epub 2009 Jun 23. Int J Hematol. 2009. PMID: 19544079 Review.

3

Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports.

Yoshida T, Kusumoto S, Inagaki A, Mori F, Ito A, Ri M, Ishida T, Komatsu H, Iida S, Sugauchi F, Tanaka Y, Mizokami M, Ueda R. Yoshida T, et al. Among authors: kusumoto s. Int J Hematol. 2010 Jun;91(5):844-9. doi: 10.1007/s12185-010-0592-y. Epub 2010 May 15. Int J Hematol. 2010. PMID: 20473594

4

Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy.

Kusumoto S, Tanaka Y, Ueda R, Mizokami M. Kusumoto S, et al. J Gastroenterol. 2011 Jan;46(1):9-16. doi: 10.1007/s00535-010-0331-4. Epub 2010 Oct 6. J Gastroenterol. 2011. PMID: 20924616 Review.

5

Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy.

Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Kusumoto S, et al. J Clin Oncol. 2011 Feb 1;29(4):e100; author reply e101. doi: 10.1200/JCO.2010.33.0332. Epub 2010 Dec 20. J Clin Oncol. 2011. PMID: 21172888 No abstract available.

6

Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy.

Sugauchi F, Tanaka Y, Kusumoto S, Matsuura K, Sugiyama M, Kurbanov F, Ueda R, Mizokami M. Sugauchi F, et al. Among authors: kusumoto s. J Med Virol. 2011 Mar;83(3):412-8. doi: 10.1002/jmv.21995. J Med Virol. 2011. PMID: 21264861

7

Reactivation of hepatitis B virus in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab.

Nakano N, Kusumoto S, Tanaka Y, Ishida T, Takeuchi S, Takatsuka Y, Akinaga S, Mizokami M, Ueda R, Utsunomiya A. Nakano N, et al. Among authors: kusumoto s. Hepatol Res. 2014 Mar;44(3):354-7. doi: 10.1111/hepr.12117. Epub 2013 Apr 18. Hepatol Res. 2014. PMID: 23601025

8

Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy?

Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Kusumoto S, et al. J Clin Oncol. 2013 Dec 10;31(35):4480. doi: 10.1200/JCO.2013.52.1278. Epub 2013 Nov 12. J Clin Oncol. 2013. PMID: 24220561 No abstract available.

9

Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy.

Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Kusumoto S, et al. Hepatology. 2014 Aug;60(2):765-6. doi: 10.1002/hep.26963. Epub 2014 Jun 18. Hepatology. 2014. PMID: 24347499 No abstract available.

10

[Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics: 1. Reactivation of hepatitis B virus and hepatitis C virus following immunosuppressive therapy].

Kusumoto S, Tanaka Y. Kusumoto S, et al. Nihon Naika Gakkai Zasshi. 2014 Jul 10;103(7):1645-53. doi: 10.2169/naika.103.1645. Nihon Naika Gakkai Zasshi. 2014. PMID: 25154260 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

570 results

Search Page

Filters